deksametazon krka 4 mg tablete
krka - farma d.o.o., radnička cesta 48, zagreb, hrvatska - deksametazon - tableta - 4 mg - urbroj: svaka tableta sadrži 4 mg deksametazona
deksametazon krka 40 mg tablete
krka - farma d.o.o., radnička cesta 48, zagreb, hrvatska - deksametazon - tableta - 40 mg - urbroj: svaka tableta sadrži 40 mg deksametazona
deksametazon krka 8 mg tablete
krka - farma d.o.o., radnička cesta 48, zagreb, hrvatska - deksametazon - tableta - 8 mg - urbroj: svaka tableta sadrži 8 mg deksametazona
lenalidomide accord
accord healthcare s.l.u. - lenalidomid - multipli mijelom - imunosupresivi - multiple myelomalenalidomide accord as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide accord as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) indiciran za liječenje odraslih bolesnika s ranije нелеченной multiplog mijeloma koji se ne oslanja transplantacije. akord леналидомид u kombinaciji s дексаметазоном indiciran za liječenje multiple myeloma kod odraslih pacijenata koji su primili barem jedan tečaj terapija. follicular lymphomalenalidomide accord in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).
dexeto 4 mg/ml otopina za injekciju/infuziju
krka d.d., novo mesto, Šmarješka cesta 6, novo mesto, slovenija - natrijev deksametazonfosfat - otopina za injekciju / infuziju - 4 mg/ml - urbroj: jedna ampula od 1 ml sadrži 4 mg deksametazonfosfata (u obliku natrijevog deksametazonfosfata)
dexeto 8 mg/2 ml otopina za injekciju/infuziju
krka d.d., novo mesto, Šmarješka cesta 6, novo mesto, slovenija - natrijev deksametazonfosfat - otopina za injekciju / infuziju - 8 mg/2 ml - urbroj: jedna ampula od 2 ml sadrži 8 mg deksametazonfosfata (u obliku natrijevog deksametazonfosfata)
sarclisa
sanofi winthrop industrie - isatuximab - multipli mijelom - antineoplastična sredstva - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.
nexpovio
stemline therapeutics b.v. - selinexor - multipli mijelom - antineoplastična sredstva - nexpovio is indicatedin combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. in combination with dexamethasone for the treatment of multiple myeloma in adult patients who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, two immunomodulatory agents and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.
deksametazon pliva 4 mg tablete
pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - deksametazon - tableta - urbroj: svaka tableta sadrži 4 mg deksametazona
deksametazon pliva 8 mg tablete
pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - deksametazon - tableta - urbroj: svaka tableta sadrži 8 mg deksametazona